Filing Details
- Accession Number:
- 0001209191-20-027880
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2020-05-08 16:17:36
- Reporting Period:
- 2020-05-06
- Accepted Time:
- 2020-05-08 16:17:36
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 875320 | Vertex Pharmaceuticals Inc / Ma | VRTX | Pharmaceutical Preparations (2834) | 043039129 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1550395 | David Altshuler | C/O Vertex Pharmaceuticals Incorporated 50 Northern Avenue Boston MA 02210 | Evp, Global Research And Cso | No | Yes | No | No |
Transaction Summary
| Sold: | 1,222 shares | Avg. Price: $272.66 | Total Value: $333,195.35 |
| Number of Shares After Transactions: | 28,902 shares | ||
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2020-05-06 | 1,222 | $155.57 | 30,124 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2020-05-06 | 271 | $270.20 | 29,853 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2020-05-06 | 210 | $271.87 | 29,643 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2020-05-06 | 461 | $273.45 | 29,182 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2020-05-06 | 280 | $274.35 | 28,902 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Stock Option (Right to Buy) | Disposition | 2020-05-06 | 1,222 | $0.00 | 1,222 | $155.57 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 8,561 | 2028-02-05 | No | 4 | M | Direct |
Footnotes
- Transaction made pursuant to Dr. Altshuler's company approved trading plan under Rule 10b5-1.
- Open market sales reported on this line occurred at a weighted average price of $270.20 (range $269.87 to $270.75).
- Dr. Altshuler undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price.
- Open market sales reported on this line occurred at a weighted average price of $271.87 (range $271.55 to $272.28).
- Open market sales reported on this line occurred at a weighted average price of $273.45 (range $273.00 to $273.96).
- Open market sales reported on this line occurred at a weighted average price of $274.35 (range $274.07 to $274.73).
- The option vests in 16 quarterly installments from 02/06/2018.
Billionaire Hedge Funds
